Send mail to Author

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
 __   __    ______   __   __    _____     _____     ______  
 \ \\/ //  /_   _//  \ \\/ //  |  ___||  /  ___||  /_   _// 
  \   //    -| ||-    \   //   | ||__   | // __     -| ||-  
  / . \\    _| ||_    / . \\   | ||__   | \\_\ ||   _| ||_  
 /_//\_\\  /_____//  /_//\_\\  |_____||  \____//   /_____// 
 `-`  --`  `-----`   `-`  --`  `-----`    `---`    `-----`
 


Back to frontdoor view

OPUS4 Logo